# FDA Inspection 1272511 - Seaway Pharma Inc. - June 18, 2025

Source: https://www.keypedia.com/records/fda_inspections/seaway-pharma-inc/ed914a53-d246-4b5f-8547-16c7b4be72d3
Source feed: FDA_Inspections

> FDA Inspection 1272511 for Seaway Pharma Inc. on June 18, 2025. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1272511
- Company Name: Seaway Pharma Inc.
- Inspection Date: 2025-06-18
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: New York District Office

## Related Documents

- [FDA Inspection 1234892 - 2024-07-25](https://www.keypedia.com/records/fda_inspections/seaway-pharma-inc/b1236eb1-94aa-435c-b037-e583a93fb011)
- [FDA Inspection 1234892 - 2024-07-25](https://www.keypedia.com/records/fda_inspections/seaway-pharma-inc/b1c80fe7-2a85-4470-850a-dbd5bde79029)
- [FDA Inspection 1220786 - 2023-09-21](https://www.keypedia.com/records/fda_inspections/seaway-pharma-inc/00542c51-5035-469b-8cd7-ef48a50bea84)
- [FDA Inspection 1151771 - 2021-09-15](https://www.keypedia.com/records/fda_inspections/seaway-pharma-inc/f3159806-05e9-4da1-8c23-c09522c5be9a)
- [FDA Inspection 1097845 - 2019-07-25](https://www.keypedia.com/records/fda_inspections/seaway-pharma-inc/59a97cdf-0bbe-45e2-95ba-871e78cda014)

Company: https://www.keypedia.com/companies/seaway-pharma-inc/c01e07b5-654d-448f-aa7e-00617078e232

Office: https://www.keypedia.com/offices/new-york-district-office/9fa3d265-16ca-438d-8a6e-b47f60dc260d